No description available.

Tikslas: Įvertinti visuomenės vaistinę pasiekiančių gydytojų išrašytų receptų klaidas. Uždaviniai: 1. Nustatyti klaidingų receptų (RP) pasitaikymo dažnį; 2. Įvertinti visuomenės vaistinę pasiekiančių RP klaidų pobūdį ir dažnį; 3. Palyginti RP pasitaikančių klaidų dažnį pagal recepto formą. Metodika: Tyrimas buvo atliktas nuo 2013 m. birželio mėn. iki 2013 m. spalio mėn. Tyrimo metodas – dokumentų analizė. Standartizuotoje analizės formoje buvo vertinamas RP išrašymo atitikimas Lietuvos Respublikos (LR) teisės aktuose (TA) nustatytiems reikalavimams, bet nefiksuojami asmenis identifikuoti galintys duomenys. Tyrime dalyvavo visi atsitiktinai pasirinktomis dienomis į tiriamą visuomenės vaistinę patekę 1 ir 3 formos RP Iš viso tirti 1174 1 ir 3 formos RP (1 formos – 806; 3 formos 368). Duomenys analizuoti taikant statistinę programą SPSS 17.00. Rezultatai: Tyrimas parodė, kad net 38% visų tirtų RP neatitinka LR TA nustatytų reikalavimų. Dažniausios klaidos - atskiros struktūrinės recepto dalys neteisingai ar visai neužpildytos. 1 formos receptuose klaidų pasitaikė dažniau nei 3 formos (p<0,05). Klaidingi buvo 43% 1 formos RP ir atitinkamai 26% 3 formos RP 1 formos receptuose daugiausiai klaidų pasitaikė informacijos apie pacientą dalyje (26% - nepabraukta, suaugusiajam ar vaikui skirtas vaistinis preparatas (VP) , 2% - su trūkstamais vardo, pavardės ar gimimo metų duomenimis bei 2% - su trūkstamu ambulatorinės kortelės nr. arba adresu). Informacijos apie vaistą dalyje:... [toliau žr. visą tekstą] / Aim: To evaluate prescribing errors made by doctors in prescriptions in community pharmacy. Tasks: 1. Identify frequency of incorrect prescriptions. 2. Estimate the nature and frequency of prescription errors. 3. Compare 1st and 3rd form frequency of incorrect prescriptions. Methodology: The study conducted between June 2013 and October 2013 in the community pharmacy of Lithuania and based on methodology - analysis of documents. The compliance of Legal Acts of the Republic of Lithuania of prescriptions was assessed in standardized analysis form, but the data which may identify a person were not recorded. The study included all randomly 1st and 3rd form prescriptions partaking in community pharmacy of selected days. Total 1174 1st and 3rd form prescription were analyzed. (1st form – 806, 3rd form - 368). The statistical analysis of the quantitative findings was performed using the data accumulation and analysis software package SPSS version 17.0 for Windows. P-values less than 0.05 were considered to be significant. Results: The study showed that 38% of all investigated prescriptions were not met the requirements of Legal Acts of the Republic of Lithuania. The most common mistake – the individual structural components of prescriptions were incorrect or incompletely filled. Errors were occurred more often in 1st form prescriptions (43%) than in 3rd form (26%) (p<0,05). The most of errors were related with information about patients in 1st form prescriptions (26% were not... [to full text]

Thesis--University of Oklahoma. / Bibliography: leaves 62-64.

Class of 2005 Abstract / Objectives: To evaluate the benefits of asthma and diabetes screening services at community pharmacies and determine patient satisfaction and willingness to pay. Methods: ASTHMA: A retrospective analysis of 342 patients were given one of two asthma screening surveys, based on whether or not they had asthma, which assessed asthma-related symptoms, associated conditions, family and social history, and the use of asthma medications. Peak flow measurements were also obtained and compared to predicted peak flow values. Based on these results, pharmacists referred patients to their physician or the emergency department if necessary. DIABETES: A retrospective analysis of 402 patients participated in diabetes screenings at Bashas’ United Drugs. Patients were given a questionnaire to complete, which included questions about diabetes diagnosis, related symptoms, and medication use. Level of control was measured by a fasting or casual finger-stick blood glucose test. Based on these results, pharmacists referred patients to their physician or the emergency department if necessary. PATIENT SATISFACTION: This is a retrospective analysis of patient satisfaction surveys collected from patients who volunteered to participate in asthma and diabetes screenings a t Bashas’ United Drugs stores. A total of 189 satisfaction surveys were collected, 73 from asthma screenings and 96 from diabetes screenings were used to evaluate patient awareness of pharmacist-run screening services, perception of pharmacist knowledge and ability to monitor health conditions, and willingness to pay for the screening services. Mean scores are based on Likert scaled data (1 = strongly disagree to 5 = strongly agree). Implications: The findings in this study suggest that community pharmacists play an essential role in the management of patients with asthma and diabetes. This study found community pharmacists are well trusted for their advice regarding medications, and would be receptive to other health related advice from their pharmacist. Respondents strongly agreed they would recommend this screening service to other patients and would be willing to pay for these services.

Objective: To measure the impact of an automated outbound telephone messaging system on herpes zoster (HZ) vaccinations among older adults in the community pharmacy setting. Design: Randomized controlled trial. Setting: 16 grocery store chain community pharmacies in Georgia and Tennessee, between December 2006 and May 2007. Patients: Adults 60 years or older who filled at least one prescription at a participating study pharmacy. Intervention: A 30-second automated outbound telephone message was delivered to patient households monthly during the first week of March through May 2007. The message advertised that older adults should speak with their pharmacist about the risk for HZ and the availability of a new vaccine. Main outcome measure: HZ vaccinations based on pharmacy profile records. Results: After 3 months, 146 and 46 vaccinations were administered to older adults among the study cohort populations, translating into HZ vaccination rates of 2.60% and 0.72% at intervention and control pharmacies, respectively (odds ratio 3.69 [95% CI 2.64-5.15], P < 0.001). Conclusion: Use of an automated outbound telephone messaging tool to inform older adults about their risk for HZ and the availability of a vaccine significantly improved vaccination rates in the community pharmacy setting.

Objective: To measure the impact of an automated outbound telephone messaging system on herpes zoster (HZ) vaccinations among older adults in the community pharmacy setting. Design: Randomized controlled trial. Setting: 16 grocery store chain community pharmacies in Georgia and Tennessee, between December 2006 and May 2007. Patients: Adults 60 years or older who filled at least one prescription at a participating study pharmacy. Intervention: A 30-second automated outbound telephone message was delivered to patient households monthly during the first week of March through May 2007. The message advertised that older adults should speak with their pharmacist about the risk for HZ and the availability of a new vaccine. Main outcome measure: HZ vaccinations based on pharmacy profile records. Results: After 3 months, 146 and 46 vaccinations were administered to older adults among the study cohort populations, translating into HZ vaccination rates of 2.60% and 0.72% at intervention and control pharmacies, respectively (odds ratio 3.69 [95% CI 2.64-5.15], P < 0.001). Conclusion: Use of an automated outbound telephone messaging tool to inform older adults about their risk for HZ and the availability of a vaccine significantly improved vaccination rates in the community pharmacy setting.

Introduction: Community-based postgraduate programs, including residencies and fellowships, have grown at a slower rate than other postgraduate programs in pharmacy. Faculty influence is cited as a significant reason why students choose to pursue postgraduate training (PGT) and thought to be a reason why students may or may not pursue community pharmacy PGT. Greater faculty encouragement of community PGT may help advance community pharmacy forward. Objective: To determine the knowledge, attitudes, and practices that pharmacy faculty have regarding community-based pharmacy postgraduate training, including community-based pharmacy residencies (CBPRs), community pharmacy fellowships (CPFs), and independent pharmacy ownership residencies (IPORs). Methods: A web-based survey was distributed to faculty members at 50 pharmacy schools, those with the 25 highest and 25 lowest 2019 residency match rates. The data collection tool was a “Knowledge, Attitudes, and Practices” (KAP) survey administered through Qualtrics and distributed by email. Descriptive statistics were used to identify gaps in faculty knowledge of PGT and trends in their attitudes and current practices. χ2 tests were used to determine differences between the two cohorts. Results: There were no significant differences between the responses of high and low residency match performers. Overall, faculty are aware of CBPRs (95%), somewhat aware of CPFs (59%), and less aware of IPORs (38%). Among those aware, the majority were unable to accurately identify the program standards of residency or fellowship. Faculty members encourage and help students pursue PGT to various levels and most seek information about PGT from national organizations and colleagues. Conclusion: This study highlights that faculty are aware of PGT opportunities in community pharmacy; however, gaps were identified in knowledge about activities and the value of community PGT. This demonstrates the need to engage faculty about the changing practice landscape of community pharmacy, the impact of faculty mentoring on students pursuing community PGT, and the importance of community PGT to advance the profession.

No description available.

Background: Lay press investigations have been published that describe pharmacist errors and the workplace environment in the community pharmacy setting. However, recent studies that explore pharmacists' perceptions of patient safety in the workplace are limited. Objectives: 1) To describe pharmacists' perceptions of workplace patient safety; 2) To compare pharmacists' perceptions of workplace patient safety across practice setting type, pharmacist roles, average hours worked per shift, and average hours worked per week. Methods: Actively licensed Tennessee pharmacists were recruited from January 1 and June 30, 2019 to complete a 13-item survey of workplace patient safety perceptions ( =1391). Descriptive statistics were calculated, and nonparametric statistical tests employed to compare differences in perceptions across practice setting type, pharmacist roles, and hours worked per shift and per week. Results: Statistically significant differences in workplace patient safety perceptions were noted across practice setting type (p values <.001) and pharmacist roles (p values <.001). The extent to which pharmacists agreed/strongly agreed that their employer provides a work environment that allows for safe patient care ranged from 29.7% of chain community pharmacists to 85% of compounding pharmacists. Fifty-two percent of staff pharmacists, 56.5% of relief pharmacists, and 58.5% of managers/pharmacists in charge agreed or strongly agreed that their employer provides a work environment that allows for safe patient care, whereas 89.3% of regional managers/directors/vice-presidents and 72.5% of clinical/specialty pharmacists indicated the same. Average hours per shift was inversely correlated with perceptions of workplace patient safety (p values <.001). Conclusion: Tennessee pharmacists' perceptions of workplace patient safety varied widely across practice setting type and pharmacist roles. Perceptions of safety were notably lower in the chain community pharmacy setting. Additional research is warranted to better understand the relationship between pharmacist perceptions and quantifiable patient safety metrics, particularly in the chain community pharmacy setting.

Yes / Objective: To investigate timely access to palliative medicines/drugs (PMs) from community pharmacies to inform palliative care service delivery. Design: Mixed methods in two sequential phases: (1) prospective audit of prescriptions and concurrent survey of patients/representatives collecting PMs from pharmacy and (2) interviews with community pharmacists (CPs) and other healthcare professionals (HCPs). Setting: Five community pharmacies in Sheffield, UK and HCPs that deliver palliative care in that community. Participants: Phase 1: five CPs: two providing access to PMs within a locally commissioned service (LCS) and three not in the LCS; 55 patients/representatives who completed the survey when accessing PMs and phase 2: 16 HCPs, including five phase 1 CPs, were interviewed. Results: The prescription audit collected information on 75 prescriptions (75 patients) with 271 individual PMs; 55 patients/representatives (73%) completed the survey. Patients/representatives reported 73% of PMs were needed urgently. In 80% of cases, patients/representatives received all PMs on the first pharmacy visit. One in five had to travel to more than one pharmacy to access PMs. The range of PMs stocked by pharmacies was the key facilitating factor. CPs reported practical issues causing difficulty keeping PMs in stock and playing a reactive role with palliative prescriptions. Confidentiality concerns were cited by other HCPs who were reluctant to share key patient information proactively with pharmacy teams. Inadequate information transfer, lack of CP integration into the care of palliative patients and poor HCP knowledge of which pharmacies stock PMs meant patients and their families were not always able to access PMs promptly. Conclusions: Consistent routine information transfer and integration of pharmacy teams in the care of palliative patients are needed to achieve timely access to PMs. Commissioners of PM access schemes should review and monitor access. HCPs need to be routinely made aware and reminded about the service and its locations. / EJM received research funding from Pharmacy Research UK and Sheffield Teaching Hospitals NHS Foundation Trust as well as support from St Luke’s Hospice, Sheffield. AB and JDM report grants from Pharmacy Research UK during the conduct of the study.